227 related articles for article (PubMed ID: 19246845)
1. Admission levels of C-reactive protein and plasminogen activator inhibitor-1 in patients with acute myocardial infarction with and without cardiogenic shock or heart failure on admission.
Akkus MN; Polat G; Yurtdas M; Akcay B; Ercetin N; Cicek D; Doven O; Sucu N
Int Heart J; 2009 Jan; 50(1):33-45. PubMed ID: 19246845
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein in acute myocardial infarction: association with heart failure.
Berton G; Cordiano R; Palmieri R; Pianca S; Pagliara V; Palatini P
Am Heart J; 2003 Jun; 145(6):1094-101. PubMed ID: 12796768
[TBL] [Abstract][Full Text] [Related]
3. Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock.
Gjesdal G; Braun OÖ; Smith JG; Scherstén F; Tydén P
BMC Cardiovasc Disord; 2018 Jan; 18(1):8. PubMed ID: 29347907
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of baseline glucose levels in acute myocardial infarction complicated by cardiogenic shock—a substudy of the IABP-SHOCK II-trial [corrected].
Abdin A; Pöss J; Fuernau G; Ouarrak T; Desch S; Eitel I; de Waha S; Zeymer U; Böhm M; Thiele H
Clin Res Cardiol; 2018 Jun; 107(6):517-523. PubMed ID: 29423774
[TBL] [Abstract][Full Text] [Related]
6. Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality.
Collet JP; Montalescot G; Vicaut E; Ankri A; Walylo F; Lesty C; Choussat R; Beygui F; Borentain M; Vignolles N; Thomas D
Circulation; 2003 Jul; 108(4):391-4. PubMed ID: 12860898
[TBL] [Abstract][Full Text] [Related]
7. Absence of gender differences in clinical outcomes in patients with cardiogenic shock complicating acute myocardial infarction. A report from the SHOCK Trial Registry.
Wong SC; Sleeper LA; Monrad ES; Menegus MA; Palazzo A; Dzavik V; Jacobs A; Jiang X; Hochman JS;
J Am Coll Cardiol; 2001 Nov; 38(5):1395-401. PubMed ID: 11691514
[TBL] [Abstract][Full Text] [Related]
8. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
[TBL] [Abstract][Full Text] [Related]
9. Association of Obesity With In-Hospital Mortality of Cardiogenic Shock Complicating Acute Myocardial Infarction.
Chatterjee K; Gupta T; Goyal A; Kolte D; Khera S; Shanbhag A; Patel K; Villablanca P; Agarwal N; Aronow WS; Menegus MA; Fonarow GC; Bhatt DL; Garcia MJ; Meena NK
Am J Cardiol; 2017 May; 119(10):1548-1554. PubMed ID: 28363355
[TBL] [Abstract][Full Text] [Related]
10. Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States.
Shah M; Patnaik S; Patel B; Ram P; Garg L; Agarwal M; Agrawal S; Arora S; Patel N; Wald J; Jorde UP
Clin Res Cardiol; 2018 Apr; 107(4):287-303. PubMed ID: 29134345
[TBL] [Abstract][Full Text] [Related]
11. Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
Singam NSV; Tabi M; Wiley B; Anavekar N; Jentzer J
Int J Cardiol; 2023 Aug; 384():38-47. PubMed ID: 37116757
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of admission high-sensitivity C-reactive protein in acute myocardial infarction patients with and without diabetes mellitus.
Lucci C; Cosentino N; Genovese S; Campodonico J; Milazzo V; De Metrio M; Rondinelli M; Riggio D; Biondi ML; Rubino M; Celentano K; Bonomi A; Capra N; Veglia F; Agostoni P; Bartorelli AL; Marenzi G
Cardiovasc Diabetol; 2020 Oct; 19(1):183. PubMed ID: 33081810
[TBL] [Abstract][Full Text] [Related]
13. Long-Term Clinical Impact of Cardiogenic Shock and Heart Failure on Admission for Acute Myocardial Infarction.
Wada H; Ogita M; Suwa S; Nakao K; Ozaki Y; Kimura K; Ako J; Noguchi T; Yasuda S; Fujimoto K; Nakama Y; Morita T; Shimizu W; Saito Y; Hirohata A; Morita Y; Inoue T; Okamura A; Mano T; Wake M; Tanabe K; Shibata Y; Owa M; Tsujita K; Funayama H; Kokubu N; Kozuma K; Uemura S; Tobaru T; Saku K; Oshima S; Nishimura K; Miyamoto Y; Ogawa H; Ishihara M;
Int Heart J; 2021 May; 62(3):520-527. PubMed ID: 33994511
[TBL] [Abstract][Full Text] [Related]
14. Long-term predictive factors of major adverse cardiac events in patients with acute myocardial infarction complicated by cardiogenic shock.
Bae EH; Lim SY; Jeong MH; Park HW; Lim JH; Hong YJ; Kim W; Kim JH; Cho JG; Ahn YK; Park JC; Suh SP; Ahn BH; Kim SH; Kang JC
Korean J Intern Med; 2005 Mar; 20(1):8-14. PubMed ID: 15906947
[TBL] [Abstract][Full Text] [Related]
15. Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.
Wigger O; Bloechlinger S; Berger D; Häner J; Zanchin T; Windecker S; Räber L; Schefold JC
Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):45-52. PubMed ID: 28838261
[TBL] [Abstract][Full Text] [Related]
16. Cardiogenic Shock From Heart Failure Versus Acute Myocardial Infarction: Clinical Characteristics, Hospital Course, and 1-Year Outcomes.
Sinha SS; Rosner CM; Tehrani BN; Maini A; Truesdell AG; Lee SB; Bagchi P; Cameron J; Damluji AA; Desai M; Desai SS; Epps KC; deFilippi C; Flanagan MC; Genovese L; Moukhachen H; Park JJ; Psotka MA; Raja A; Shah P; Sherwood MW; Singh R; Tang D; Young KD; Welch T; O'Connor CM; Batchelor WB
Circ Heart Fail; 2022 Jun; 15(6):e009279. PubMed ID: 35510546
[TBL] [Abstract][Full Text] [Related]
17. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
van Diepen S; Newby LK; Lopes RD; Stebbins A; Hasselblad V; James S; Roe MT; Ezekowitz JA; Moliterno DJ; Neumann FJ; Reist C; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Granger CB; Theroux P;
Int J Cardiol; 2013 Oct; 168(3):2127-33. PubMed ID: 23394896
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors of major adverse cardiac events in acute myocardial infarction patients complicated by cardiogenic shock undergoing primary percutaneous coronary intervention.
Lim SY; Jeong MH; Bae EH; Kim W; Kim JH; Hong YJ; Park HW; Kang DG; Lee YS; Kim KH; Lee SH; Yun KH; Hong SN; Cho JG; Ahn YK; Park JC; Ahn BH; Kim SH; Kang JC
Circ J; 2005 Feb; 69(2):154-8. PubMed ID: 15671605
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte and its Subtypes as Predictors of Short-Term Outcome in Cardiogenic Shock Complicating Acute Myocardial Infarction: A Cohort Study.
Sasmita BR; Zhu Y; Gan H; Hu X; Xue Y; Xiang Z; Liu G; Luo S; Huang B
Shock; 2022 Mar; 57(3):351-359. PubMed ID: 34710884
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of admission blood glucose level in patients with and without diabetes mellitus who sustain ST segment elevation myocardial infarction complicated by cardiogenic shock.
Yang JH; Song PS; Song YB; Hahn JY; Choi SH; Choi JH; Lee SH; Jeong MH; Kim YJ; Gwon HC
Crit Care; 2013 Oct; 17(5):R218. PubMed ID: 24090250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
